 Monika Fleshner
Concepts (699)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress, Psychological | 59 | 2017 | 1147 | 7.010 |
Why?
| | Stress, Physiological | 47 | 2019 | 453 | 6.820 |
Why?
| | Prebiotics | 8 | 2025 | 28 | 4.620 |
Why?
| | Physical Conditioning, Animal | 22 | 2019 | 243 | 4.100 |
Why?
| | Rats, Inbred F344 | 48 | 2019 | 268 | 3.260 |
Why?
| | Rats | 137 | 2024 | 5592 | 3.250 |
Why?
| | Motor Activity | 28 | 2019 | 720 | 3.140 |
Why?
| | HSP72 Heat-Shock Proteins | 17 | 2014 | 31 | 3.010 |
Why?
| | Helplessness, Learned | 13 | 2016 | 67 | 2.820 |
Why?
| | Corticosterone | 38 | 2016 | 244 | 2.130 |
Why?
| | Running | 14 | 2016 | 228 | 2.070 |
Why?
| | Brain | 27 | 2024 | 2930 | 1.890 |
Why?
| | Rats, Sprague-Dawley | 71 | 2024 | 2525 | 1.830 |
Why?
| | Glucans | 2 | 2025 | 22 | 1.740 |
Why?
| | Oligosaccharides | 2 | 2025 | 60 | 1.710 |
Why?
| | Heat-Shock Proteins | 10 | 2024 | 138 | 1.680 |
Why?
| | Animals | 164 | 2025 | 38030 | 1.670 |
Why?
| | Gastrointestinal Microbiome | 5 | 2025 | 771 | 1.490 |
Why?
| | Cytokines | 17 | 2024 | 2061 | 1.420 |
Why?
| | Electroshock | 28 | 2015 | 145 | 1.400 |
Why?
| | Immune System | 9 | 2017 | 179 | 1.390 |
Why?
| | Fear | 17 | 2015 | 366 | 1.360 |
Why?
| | Escherichia coli Infections | 9 | 2012 | 129 | 1.310 |
Why?
| | Exosomes | 5 | 2017 | 104 | 1.310 |
Why?
| | Circadian Rhythm | 7 | 2021 | 513 | 1.250 |
Why?
| | Hemocyanins | 19 | 2008 | 61 | 1.220 |
Why?
| | Interleukin-1beta | 6 | 2016 | 395 | 1.210 |
Why?
| | Inflammation | 12 | 2024 | 2877 | 1.120 |
Why?
| | Bacteria | 7 | 2024 | 889 | 1.110 |
Why?
| | Inflammasomes | 3 | 2016 | 146 | 1.110 |
Why?
| | Proto-Oncogene Proteins c-fos | 11 | 2019 | 196 | 1.090 |
Why?
| | Physical Exertion | 6 | 2012 | 207 | 1.080 |
Why?
| | Immunity, Innate | 9 | 2014 | 846 | 1.080 |
Why?
| | Exercise | 17 | 2024 | 2193 | 1.070 |
Why?
| | Corpus Striatum | 7 | 2017 | 179 | 1.070 |
Why?
| | Gastrointestinal Tract | 3 | 2016 | 208 | 1.050 |
Why?
| | Lactoferrin | 2 | 2018 | 36 | 1.040 |
Why?
| | Spleen | 13 | 2013 | 508 | 1.040 |
Why?
| | Anxiety | 10 | 2018 | 1104 | 1.020 |
Why?
| | Immunoglobulin M | 11 | 2008 | 284 | 0.990 |
Why?
| | Serotonin | 10 | 2019 | 293 | 0.970 |
Why?
| | Male | 145 | 2024 | 72035 | 0.960 |
Why?
| | Feces | 4 | 2025 | 513 | 0.960 |
Why?
| | Diet | 5 | 2024 | 1271 | 0.950 |
Why?
| | Neuronal Plasticity | 12 | 2018 | 309 | 0.930 |
Why?
| | Hypergravity | 1 | 2025 | 6 | 0.910 |
Why?
| | Interleukin-1 | 15 | 2008 | 961 | 0.910 |
Why?
| | Antibody Formation | 10 | 2008 | 294 | 0.890 |
Why?
| | Amygdala | 7 | 2017 | 198 | 0.880 |
Why?
| | MicroRNAs | 3 | 2017 | 700 | 0.860 |
Why?
| | Sympathetic Nervous System | 4 | 2014 | 178 | 0.860 |
Why?
| | Receptors, Adrenergic, alpha-1 | 7 | 2014 | 45 | 0.820 |
Why?
| | Bile Acids and Salts | 2 | 2024 | 164 | 0.810 |
Why?
| | Lipopolysaccharides | 11 | 2024 | 863 | 0.810 |
Why?
| | Raphe Nuclei | 7 | 2019 | 110 | 0.780 |
Why?
| | Behavior, Animal | 13 | 2019 | 519 | 0.770 |
Why?
| | Hippocampus | 18 | 2017 | 965 | 0.740 |
Why?
| | RNA, Ribosomal, 16S | 5 | 2025 | 558 | 0.730 |
Why?
| | Conditioning, Classical | 7 | 2015 | 120 | 0.710 |
Why?
| | Adipose Tissue | 3 | 2016 | 651 | 0.700 |
Why?
| | Glycolipids | 2 | 2019 | 52 | 0.670 |
Why?
| | Neuroendocrine Cells | 1 | 2020 | 33 | 0.660 |
Why?
| | Catecholamines | 7 | 2014 | 87 | 0.650 |
Why?
| | Stress Disorders, Post-Traumatic | 8 | 2021 | 884 | 0.640 |
Why?
| | Immunoglobulin G | 13 | 2008 | 893 | 0.640 |
Why?
| | Conditioning, Operant | 5 | 2012 | 97 | 0.640 |
Why?
| | Dopamine | 3 | 2015 | 283 | 0.630 |
Why?
| | Receptor, Serotonin, 5-HT2C | 4 | 2012 | 14 | 0.610 |
Why?
| | Microbiota | 2 | 2019 | 781 | 0.610 |
Why?
| | Gene Expression Regulation | 8 | 2014 | 2603 | 0.610 |
Why?
| | Glycoproteins | 2 | 2019 | 355 | 0.600 |
Why?
| | Tumor Necrosis Factor-alpha | 7 | 2016 | 1217 | 0.600 |
Why?
| | Body Weight | 15 | 2016 | 976 | 0.570 |
Why?
| | Mentors | 1 | 2021 | 218 | 0.560 |
Why?
| | Brain-Derived Neurotrophic Factor | 5 | 2018 | 148 | 0.560 |
Why?
| | Interleukin-10 | 7 | 2016 | 309 | 0.560 |
Why?
| | Prefrontal Cortex | 5 | 2017 | 328 | 0.560 |
Why?
| | Microglia | 2 | 2021 | 268 | 0.550 |
Why?
| | Sleep | 4 | 2021 | 901 | 0.520 |
Why?
| | Alarmins | 1 | 2017 | 27 | 0.520 |
Why?
| | Fatigue | 3 | 2012 | 361 | 0.510 |
Why?
| | Signal Transduction | 10 | 2023 | 5221 | 0.510 |
Why?
| | Food Deprivation | 1 | 2016 | 27 | 0.500 |
Why?
| | Escape Reaction | 6 | 2012 | 56 | 0.500 |
Why?
| | Inflammation Mediators | 4 | 2013 | 508 | 0.500 |
Why?
| | Vagus Nerve | 7 | 2000 | 91 | 0.500 |
Why?
| | Analysis of Variance | 15 | 2015 | 1304 | 0.480 |
Why?
| | Sleep, REM | 1 | 2016 | 44 | 0.470 |
Why?
| | Receptors, Glucocorticoid | 4 | 2013 | 138 | 0.470 |
Why?
| | Butyrates | 1 | 2016 | 67 | 0.460 |
Why?
| | Emotions | 3 | 2018 | 577 | 0.460 |
Why?
| | Central Nervous System | 2 | 2016 | 281 | 0.460 |
Why?
| | Association Learning | 3 | 2010 | 71 | 0.460 |
Why?
| | Neuroimmunomodulation | 8 | 2003 | 68 | 0.450 |
Why?
| | RNA, Messenger | 12 | 2018 | 2829 | 0.450 |
Why?
| | Mood Disorders | 1 | 2016 | 139 | 0.450 |
Why?
| | Macrophages, Peritoneal | 2 | 2014 | 89 | 0.450 |
Why?
| | Norepinephrine | 6 | 2006 | 196 | 0.440 |
Why?
| | Chemokines | 2 | 2012 | 218 | 0.430 |
Why?
| | Interleukin-6 | 7 | 2016 | 780 | 0.430 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1982 | 0.430 |
Why?
| | Interleukin-18 | 2 | 2012 | 235 | 0.430 |
Why?
| | Serum | 1 | 2014 | 56 | 0.420 |
Why?
| | Extracellular Space | 3 | 2005 | 120 | 0.420 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2016 | 208 | 0.410 |
Why?
| | Receptors, Adrenergic | 1 | 2013 | 20 | 0.410 |
Why?
| | Time Factors | 25 | 2016 | 7155 | 0.410 |
Why?
| | Arousal | 9 | 2021 | 157 | 0.410 |
Why?
| | Sleep Deprivation | 4 | 2020 | 206 | 0.400 |
Why?
| | Adaptation, Physiological | 6 | 2007 | 569 | 0.400 |
Why?
| | Adipose Tissue, White | 1 | 2013 | 43 | 0.400 |
Why?
| | Receptor, Serotonin, 5-HT1A | 3 | 2016 | 36 | 0.400 |
Why?
| | Reward | 3 | 2016 | 245 | 0.390 |
Why?
| | Chemokine CCL2 | 4 | 2014 | 115 | 0.390 |
Why?
| | Glucocorticoids | 5 | 2012 | 533 | 0.380 |
Why?
| | Psychoneuroimmunology | 3 | 2005 | 9 | 0.380 |
Why?
| | Transcortin | 6 | 2007 | 14 | 0.380 |
Why?
| | Intestines | 1 | 2015 | 358 | 0.370 |
Why?
| | Immune Tolerance | 3 | 2005 | 379 | 0.370 |
Why?
| | Injections, Intraperitoneal | 11 | 2008 | 116 | 0.370 |
Why?
| | Respiratory Tract Infections | 2 | 2016 | 396 | 0.360 |
Why?
| | Antigens | 4 | 2003 | 347 | 0.360 |
Why?
| | Obesity, Abdominal | 1 | 2012 | 46 | 0.360 |
Why?
| | Aminopyridines | 3 | 2009 | 127 | 0.350 |
Why?
| | Nitric Oxide | 6 | 2014 | 897 | 0.350 |
Why?
| | Myeloid Cells | 1 | 2012 | 148 | 0.340 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2016 | 366 | 0.340 |
Why?
| | Body Temperature | 5 | 2014 | 228 | 0.330 |
Why?
| | Mental Health | 2 | 2015 | 776 | 0.330 |
Why?
| | Mifepristone | 3 | 2001 | 64 | 0.330 |
Why?
| | Freezing Reaction, Cataleptic | 4 | 2012 | 27 | 0.320 |
Why?
| | Limbic System | 1 | 2010 | 55 | 0.320 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 8 | 2014 | 850 | 0.320 |
Why?
| | Neurons | 8 | 2017 | 1640 | 0.320 |
Why?
| | Memory | 9 | 2015 | 294 | 0.310 |
Why?
| | Metagenome | 1 | 2010 | 149 | 0.310 |
Why?
| | Volition | 1 | 2009 | 34 | 0.310 |
Why?
| | Random Allocation | 3 | 2016 | 363 | 0.300 |
Why?
| | Space Flight | 2 | 2000 | 71 | 0.300 |
Why?
| | Extracellular Fluid | 3 | 2006 | 36 | 0.300 |
Why?
| | Brain Chemistry | 3 | 2005 | 116 | 0.300 |
Why?
| | Disease Models, Animal | 13 | 2016 | 4556 | 0.300 |
Why?
| | Depression | 3 | 2012 | 1533 | 0.300 |
Why?
| | Serotonin 5-HT2 Receptor Antagonists | 1 | 2008 | 10 | 0.290 |
Why?
| | Locomotion | 2 | 2012 | 105 | 0.290 |
Why?
| | Lipid Droplets | 2 | 2019 | 21 | 0.290 |
Why?
| | Electric Stimulation | 9 | 2013 | 276 | 0.290 |
Why?
| | Up-Regulation | 4 | 2012 | 851 | 0.290 |
Why?
| | Predatory Behavior | 5 | 2011 | 51 | 0.280 |
Why?
| | Exercise Therapy | 3 | 2008 | 467 | 0.280 |
Why?
| | Indoles | 3 | 2009 | 501 | 0.280 |
Why?
| | Fluvoxamine | 1 | 2008 | 16 | 0.280 |
Why?
| | Exercise Test | 3 | 2007 | 634 | 0.280 |
Why?
| | Antibodies | 3 | 2005 | 401 | 0.270 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2008 | 61 | 0.270 |
Why?
| | Homeostasis | 3 | 2017 | 640 | 0.270 |
Why?
| | B-Lymphocytes | 2 | 2003 | 876 | 0.270 |
Why?
| | Heat-Shock Response | 2 | 2024 | 77 | 0.260 |
Why?
| | Adrenal Glands | 8 | 2008 | 77 | 0.260 |
Why?
| | Mycobacterium | 2 | 2021 | 116 | 0.260 |
Why?
| | Adrenalectomy | 11 | 2005 | 71 | 0.260 |
Why?
| | Pituitary-Adrenal System | 4 | 2012 | 165 | 0.260 |
Why?
| | Humans | 46 | 2024 | 144261 | 0.260 |
Why?
| | Extinction, Psychological | 3 | 2015 | 92 | 0.250 |
Why?
| | Hypothalamo-Hypophyseal System | 4 | 2012 | 198 | 0.250 |
Why?
| | Receptors, Catecholamine | 1 | 2006 | 4 | 0.250 |
Why?
| | Physical Fitness | 2 | 2006 | 209 | 0.240 |
Why?
| | Receptors, Dopamine D2 | 3 | 2014 | 93 | 0.240 |
Why?
| | Heart Rate | 6 | 2016 | 849 | 0.240 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2005 | 19 | 0.240 |
Why?
| | Adjuvants, Immunologic | 4 | 2003 | 245 | 0.240 |
Why?
| | Spike Glycoprotein, Coronavirus | 2 | 2024 | 130 | 0.240 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 496 | 0.230 |
Why?
| | Galactose | 1 | 2025 | 34 | 0.230 |
Why?
| | Vagotomy | 8 | 2000 | 33 | 0.230 |
Why?
| | Neural Pathways | 4 | 2015 | 311 | 0.230 |
Why?
| | Receptor, Serotonin, 5-HT1B | 1 | 2005 | 6 | 0.230 |
Why?
| | In Situ Hybridization | 4 | 2012 | 319 | 0.220 |
Why?
| | Cognition | 6 | 2024 | 1258 | 0.220 |
Why?
| | Immunomodulation | 2 | 2017 | 101 | 0.220 |
Why?
| | Physical Endurance | 1 | 2006 | 278 | 0.220 |
Why?
| | Adrenocorticotropic Hormone | 7 | 2013 | 147 | 0.220 |
Why?
| | Sick Role | 1 | 2004 | 19 | 0.210 |
Why?
| | Dose-Response Relationship, Drug | 10 | 2013 | 2026 | 0.210 |
Why?
| | Immunization | 6 | 2021 | 374 | 0.210 |
Why?
| | Persian Gulf Syndrome | 1 | 2024 | 18 | 0.210 |
Why?
| | Psychomotor Performance | 3 | 2019 | 328 | 0.210 |
Why?
| | Physiology | 1 | 2024 | 13 | 0.210 |
Why?
| | Memory Disorders | 3 | 2013 | 193 | 0.210 |
Why?
| | Long-Term Potentiation | 7 | 1999 | 200 | 0.200 |
Why?
| | Membrane Transport Proteins | 1 | 2005 | 154 | 0.200 |
Why?
| | Encephalitis | 1 | 2005 | 139 | 0.200 |
Why?
| | Morphine | 5 | 2011 | 168 | 0.200 |
Why?
| | CD5 Antigens | 1 | 2003 | 10 | 0.200 |
Why?
| | Social Behavior | 4 | 2016 | 288 | 0.200 |
Why?
| | CD11 Antigens | 1 | 2003 | 30 | 0.190 |
Why?
| | Hypothalamus | 4 | 2017 | 153 | 0.190 |
Why?
| | Propranolol | 3 | 2008 | 44 | 0.190 |
Why?
| | Genes, fos | 1 | 2003 | 37 | 0.190 |
Why?
| | Muscle Strength | 1 | 2006 | 330 | 0.190 |
Why?
| | Lung | 1 | 2016 | 4108 | 0.190 |
Why?
| | Myocardium | 4 | 2007 | 939 | 0.190 |
Why?
| | Microdialysis | 4 | 2015 | 53 | 0.180 |
Why?
| | Protein Biosynthesis | 1 | 2005 | 458 | 0.180 |
Why?
| | B-Lymphocyte Subsets | 1 | 2002 | 80 | 0.180 |
Why?
| | Medicine | 1 | 2024 | 125 | 0.180 |
Why?
| | Depressive Disorder | 3 | 2012 | 374 | 0.180 |
Why?
| | Lymph Nodes | 5 | 2006 | 502 | 0.180 |
Why?
| | Maze Learning | 6 | 2015 | 103 | 0.180 |
Why?
| | Dehydroepiandrosterone | 3 | 1997 | 50 | 0.180 |
Why?
| | Cross-Over Studies | 1 | 2024 | 600 | 0.180 |
Why?
| | T-Lymphocyte Subsets | 2 | 1995 | 415 | 0.180 |
Why?
| | Dehydroepiandrosterone Sulfate | 3 | 1999 | 42 | 0.170 |
Why?
| | Bacteroidetes | 1 | 2021 | 21 | 0.170 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2000 | 1128 | 0.170 |
Why?
| | Interferon-gamma | 4 | 2001 | 784 | 0.170 |
Why?
| | Adrenergic beta-Antagonists | 3 | 2008 | 250 | 0.170 |
Why?
| | Tyrosine 3-Monooxygenase | 3 | 2016 | 71 | 0.170 |
Why?
| | Gene Expression | 2 | 2018 | 1487 | 0.170 |
Why?
| | Sex Characteristics | 2 | 2006 | 789 | 0.170 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 592 | 0.170 |
Why?
| | Weightlessness Simulation | 1 | 2000 | 6 | 0.170 |
Why?
| | Pituitary Gland | 5 | 2006 | 148 | 0.160 |
Why?
| | Weightlessness | 1 | 2000 | 39 | 0.160 |
Why?
| | Acoustic Stimulation | 7 | 2015 | 333 | 0.160 |
Why?
| | Antidepressive Agents, Tricyclic | 2 | 2013 | 31 | 0.160 |
Why?
| | Neurosecretory Systems | 1 | 2000 | 31 | 0.160 |
Why?
| | Radiation Effects | 1 | 1999 | 7 | 0.160 |
Why?
| | Avoidance Learning | 2 | 2013 | 64 | 0.150 |
Why?
| | Astronauts | 1 | 1999 | 30 | 0.150 |
Why?
| | Exploratory Behavior | 3 | 2015 | 86 | 0.150 |
Why?
| | Dentate Gyrus | 2 | 2010 | 40 | 0.150 |
Why?
| | Mental Recall | 4 | 1997 | 222 | 0.150 |
Why?
| | Fever | 3 | 2011 | 311 | 0.150 |
Why?
| | Serotonergic Neurons | 1 | 2019 | 29 | 0.150 |
Why?
| | Tryptophan Hydroxylase | 1 | 2019 | 54 | 0.150 |
Why?
| | Blood Proteins | 2 | 2002 | 249 | 0.150 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5988 | 0.150 |
Why?
| | Chromatography, Liquid | 1 | 2021 | 454 | 0.150 |
Why?
| | Citrate (si)-Synthase | 4 | 2007 | 57 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 4 | 2024 | 478 | 0.150 |
Why?
| | Prazosin | 2 | 2011 | 25 | 0.150 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 52 | 0.140 |
Why?
| | RNA, Bacterial | 1 | 2020 | 189 | 0.140 |
Why?
| | Serotonin 5-HT2 Receptor Agonists | 2 | 2008 | 6 | 0.140 |
Why?
| | Mice | 8 | 2025 | 18329 | 0.140 |
Why?
| | Cells, Cultured | 5 | 2014 | 4146 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 576 | 0.140 |
Why?
| | Cats | 5 | 2015 | 228 | 0.130 |
Why?
| | Dexamethasone | 3 | 2001 | 370 | 0.130 |
Why?
| | Biomedical Research | 1 | 2024 | 709 | 0.130 |
Why?
| | Toll-Like Receptors | 2 | 2011 | 194 | 0.130 |
Why?
| | Lymphocytes | 4 | 2011 | 382 | 0.130 |
Why?
| | Peptides | 2 | 2013 | 995 | 0.130 |
Why?
| | Exercise Movement Techniques | 1 | 2016 | 7 | 0.120 |
Why?
| | Analgesics, Opioid | 3 | 2012 | 1131 | 0.120 |
Why?
| | Female | 22 | 2025 | 77976 | 0.120 |
Why?
| | Behavior | 2 | 2006 | 91 | 0.120 |
Why?
| | Leukocyte Count | 3 | 2002 | 316 | 0.120 |
Why?
| | Immunosuppressive Agents | 1 | 2001 | 846 | 0.120 |
Why?
| | Immunoglobulins | 1 | 1996 | 160 | 0.120 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2016 | 158 | 0.120 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 70 | 0.120 |
Why?
| | Bacterial Vaccines | 1 | 2016 | 63 | 0.120 |
Why?
| | Dysgammaglobulinemia | 1 | 1995 | 2 | 0.110 |
Why?
| | IgG Deficiency | 1 | 1995 | 6 | 0.110 |
Why?
| | Aging | 3 | 2004 | 1964 | 0.110 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2016 | 139 | 0.110 |
Why?
| | Leukocyte Common Antigens | 1 | 1995 | 88 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 244 | 0.110 |
Why?
| | Immunity | 3 | 2002 | 139 | 0.110 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1995 | 51 | 0.110 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 187 | 0.110 |
Why?
| | Host-Pathogen Interactions | 2 | 2015 | 371 | 0.110 |
Why?
| | Symbiosis | 1 | 2015 | 81 | 0.110 |
Why?
| | CD4 Antigens | 1 | 1995 | 139 | 0.110 |
Why?
| | Muscle, Skeletal | 5 | 2007 | 1792 | 0.110 |
Why?
| | Tyrosine | 2 | 2005 | 221 | 0.110 |
Why?
| | Dynorphins | 1 | 2014 | 8 | 0.110 |
Why?
| | Neuralgia | 1 | 2016 | 144 | 0.110 |
Why?
| | Enkephalins | 1 | 2014 | 21 | 0.110 |
Why?
| | Hydrocortisone | 3 | 2015 | 304 | 0.110 |
Why?
| | Receptor, Adenosine A1 | 1 | 2014 | 11 | 0.110 |
Why?
| | Receptor, Adenosine A2A | 1 | 2014 | 23 | 0.110 |
Why?
| | Nitrites | 3 | 2016 | 89 | 0.110 |
Why?
| | Culture Media | 1 | 2014 | 160 | 0.100 |
Why?
| | Peritoneum | 3 | 2003 | 45 | 0.100 |
Why?
| | Receptors, Dopamine D1 | 1 | 2014 | 35 | 0.100 |
Why?
| | Tail | 4 | 1998 | 29 | 0.100 |
Why?
| | Metabolomics | 1 | 2020 | 726 | 0.100 |
Why?
| | Convulsants | 1 | 1993 | 8 | 0.100 |
Why?
| | Primary Cell Culture | 1 | 2014 | 173 | 0.100 |
Why?
| | Anxiety Disorders | 2 | 2008 | 368 | 0.100 |
Why?
| | Adrenergic alpha-Antagonists | 2 | 2005 | 34 | 0.100 |
Why?
| | Carbolines | 1 | 1993 | 35 | 0.100 |
Why?
| | Acute-Phase Reaction | 2 | 2007 | 37 | 0.100 |
Why?
| | Immunity, Cellular | 3 | 2005 | 272 | 0.100 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2013 | 47 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 964 | 0.100 |
Why?
| | Hyperalgesia | 3 | 2016 | 131 | 0.100 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2013 | 75 | 0.100 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2017 | 449 | 0.100 |
Why?
| | History, 21st Century | 2 | 2024 | 219 | 0.100 |
Why?
| | Bradykinin | 1 | 2013 | 48 | 0.100 |
Why?
| | Molecular Probes | 1 | 2013 | 33 | 0.100 |
Why?
| | Amnesia | 2 | 2011 | 47 | 0.100 |
Why?
| | Colitis | 1 | 2016 | 280 | 0.100 |
Why?
| | Telemetry | 1 | 2013 | 41 | 0.100 |
Why?
| | History, 20th Century | 2 | 2024 | 324 | 0.100 |
Why?
| | Macrophage Inflammatory Proteins | 1 | 2012 | 11 | 0.090 |
Why?
| | Cues | 3 | 2015 | 326 | 0.090 |
Why?
| | Diaphragm | 3 | 1998 | 49 | 0.090 |
Why?
| | Reaction Time | 3 | 2012 | 438 | 0.090 |
Why?
| | Synaptotagmin I | 1 | 2012 | 15 | 0.090 |
Why?
| | Membrane Proteins | 2 | 2012 | 1165 | 0.090 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1322 | 0.090 |
Why?
| | Thymus Gland | 3 | 2008 | 311 | 0.090 |
Why?
| | Phenylephrine | 2 | 2001 | 75 | 0.090 |
Why?
| | Caspase Inhibitors | 1 | 2012 | 81 | 0.090 |
Why?
| | Body Fat Distribution | 1 | 2012 | 45 | 0.090 |
Why?
| | Life Style | 2 | 2005 | 475 | 0.090 |
Why?
| | Fetal Blood | 1 | 2014 | 342 | 0.090 |
Why?
| | Lipid Bilayers | 1 | 2013 | 103 | 0.090 |
Why?
| | Area Under Curve | 1 | 2013 | 329 | 0.090 |
Why?
| | Rats, Nude | 1 | 2012 | 25 | 0.090 |
Why?
| | Injections, Subcutaneous | 2 | 2003 | 164 | 0.090 |
Why?
| | Gliosarcoma | 1 | 1992 | 8 | 0.090 |
Why?
| | Caspase 1 | 1 | 2012 | 148 | 0.090 |
Why?
| | Thiazepines | 2 | 2013 | 6 | 0.090 |
Why?
| | Pulmonary Fibrosis | 1 | 2016 | 395 | 0.090 |
Why?
| | Lymphocyte Transfusion | 1 | 1992 | 20 | 0.090 |
Why?
| | Cattle | 1 | 2014 | 999 | 0.090 |
Why?
| | Veterans | 1 | 2024 | 1600 | 0.090 |
Why?
| | Lymphocyte Count | 2 | 2003 | 164 | 0.090 |
Why?
| | Cell Communication | 1 | 2014 | 324 | 0.090 |
Why?
| | Saimiri | 1 | 2011 | 9 | 0.090 |
Why?
| | Mental Disorders | 1 | 2020 | 1138 | 0.090 |
Why?
| | Neurobiology | 1 | 2011 | 14 | 0.090 |
Why?
| | Macrophages | 2 | 2000 | 1510 | 0.090 |
Why?
| | Uric Acid | 1 | 2012 | 166 | 0.090 |
Why?
| | Locus Coeruleus | 1 | 2011 | 24 | 0.090 |
Why?
| | Cell Survival | 1 | 2014 | 1098 | 0.090 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2011 | 51 | 0.080 |
Why?
| | Body Composition | 1 | 2015 | 704 | 0.080 |
Why?
| | Receptors, Opioid, delta | 1 | 2010 | 10 | 0.080 |
Why?
| | Laparotomy | 1 | 2011 | 112 | 0.080 |
Why?
| | Endocrine Glands | 1 | 1990 | 14 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2012 | 139 | 0.080 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 275 | 0.080 |
Why?
| | C-Reactive Protein | 3 | 2024 | 416 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 341 | 0.080 |
Why?
| | Aged | 5 | 2008 | 25850 | 0.080 |
Why?
| | Interleukin-2 | 1 | 1992 | 437 | 0.080 |
Why?
| | DNA Primers | 1 | 2011 | 511 | 0.080 |
Why?
| | Epinephrine | 3 | 2004 | 155 | 0.080 |
Why?
| | Rats, Inbred Strains | 6 | 1995 | 321 | 0.080 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 276 | 0.080 |
Why?
| | Microinjections | 2 | 2008 | 92 | 0.080 |
Why?
| | Pain | 4 | 2011 | 777 | 0.080 |
Why?
| | Liver | 4 | 2006 | 1884 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1715 | 0.080 |
Why?
| | Cell Count | 2 | 2002 | 320 | 0.080 |
Why?
| | Stress Disorders, Traumatic | 1 | 2009 | 24 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 459 | 0.080 |
Why?
| | CA1 Region, Hippocampal | 1 | 2009 | 51 | 0.070 |
Why?
| | Glucose | 1 | 2014 | 1046 | 0.070 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2001 | 65 | 0.070 |
Why?
| | Reference Values | 5 | 2007 | 797 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 509 | 0.070 |
Why?
| | Neutrophils | 3 | 2011 | 1134 | 0.070 |
Why?
| | Naltrexone | 4 | 1994 | 117 | 0.070 |
Why?
| | Nadolol | 1 | 2008 | 3 | 0.070 |
Why?
| | Analgesics | 1 | 1990 | 228 | 0.070 |
Why?
| | Habituation, Psychophysiologic | 1 | 2008 | 58 | 0.070 |
Why?
| | Insulin | 2 | 2016 | 2501 | 0.070 |
Why?
| | Immunotherapy, Adoptive | 1 | 1992 | 337 | 0.070 |
Why?
| | Isoproterenol | 1 | 2008 | 96 | 0.070 |
Why?
| | Flow Cytometry | 2 | 2003 | 1172 | 0.070 |
Why?
| | Pyrazines | 1 | 2008 | 92 | 0.070 |
Why?
| | Injections, Intraventricular | 4 | 1998 | 56 | 0.070 |
Why?
| | Adrenergic beta-Agonists | 1 | 2008 | 91 | 0.070 |
Why?
| | Reinforcement Schedule | 1 | 2007 | 25 | 0.070 |
Why?
| | Escherichia coli | 2 | 2002 | 852 | 0.070 |
Why?
| | Lipids | 1 | 2012 | 700 | 0.070 |
Why?
| | Substantia Nigra | 1 | 2008 | 63 | 0.070 |
Why?
| | Aggression | 1 | 1989 | 179 | 0.070 |
Why?
| | Nerve Net | 1 | 2010 | 285 | 0.070 |
Why?
| | Weight Loss | 1 | 1993 | 832 | 0.060 |
Why?
| | Mesentery | 2 | 1998 | 45 | 0.060 |
Why?
| | Biogenic Monoamines | 1 | 2006 | 15 | 0.060 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2006 | 44 | 0.060 |
Why?
| | Recombinant Proteins | 5 | 2000 | 1367 | 0.060 |
Why?
| | Computational Biology | 1 | 2011 | 680 | 0.060 |
Why?
| | Blood Glucose | 1 | 2016 | 2312 | 0.060 |
Why?
| | Fluoxetine | 1 | 2006 | 54 | 0.060 |
Why?
| | Estrous Cycle | 1 | 2006 | 23 | 0.060 |
Why?
| | Cell Adhesion Molecules | 1 | 2007 | 177 | 0.060 |
Why?
| | Piperazines | 1 | 2008 | 380 | 0.060 |
Why?
| | Pulmonary Edema | 1 | 2006 | 106 | 0.060 |
Why?
| | Adaptation, Psychological | 1 | 2011 | 706 | 0.060 |
Why?
| | Labetalol | 1 | 2005 | 6 | 0.060 |
Why?
| | Mianserin | 1 | 2005 | 3 | 0.060 |
Why?
| | Methyltyrosines | 1 | 2005 | 3 | 0.060 |
Why?
| | Hypophysectomy | 1 | 2005 | 15 | 0.060 |
Why?
| | Immunoglobulin alpha-Chains | 1 | 2005 | 1 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2730 | 0.060 |
Why?
| | Hypertrophy | 2 | 2007 | 127 | 0.060 |
Why?
| | Phosphorylation | 3 | 2017 | 1732 | 0.060 |
Why?
| | Exocytosis | 1 | 2005 | 84 | 0.060 |
Why?
| | Evoked Potentials | 3 | 1996 | 128 | 0.050 |
Why?
| | Spectrophotometry | 1 | 2005 | 60 | 0.050 |
Why?
| | Postural Balance | 1 | 2008 | 240 | 0.050 |
Why?
| | Specific Pathogen-Free Organisms | 2 | 2002 | 58 | 0.050 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 62 | 0.050 |
Why?
| | Chemokines, CX3C | 1 | 2004 | 10 | 0.050 |
Why?
| | RNA | 1 | 2011 | 939 | 0.050 |
Why?
| | Progesterone | 1 | 2006 | 255 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2016 | 1980 | 0.050 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 28 | 0.050 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2004 | 55 | 0.050 |
Why?
| | Down-Regulation | 1 | 2006 | 627 | 0.050 |
Why?
| | Physical Education and Training | 1 | 2024 | 71 | 0.050 |
Why?
| | Antibody Specificity | 1 | 2004 | 181 | 0.050 |
Why?
| | Lymphocyte Activation | 2 | 2000 | 1126 | 0.050 |
Why?
| | Cholesterol, HDL | 1 | 2005 | 194 | 0.050 |
Why?
| | Concanavalin A | 1 | 2003 | 71 | 0.050 |
Why?
| | Hypertension | 1 | 2013 | 1254 | 0.050 |
Why?
| | Blood Pressure | 4 | 2015 | 1759 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 235 | 0.050 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2003 | 19 | 0.050 |
Why?
| | Immunologic Factors | 1 | 2005 | 255 | 0.050 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2003 | 8 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2006 | 383 | 0.050 |
Why?
| | Frontal Lobe | 1 | 2004 | 159 | 0.050 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 35 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2005 | 377 | 0.050 |
Why?
| | Adult | 10 | 2024 | 40262 | 0.050 |
Why?
| | Estrogens | 1 | 2006 | 380 | 0.050 |
Why?
| | Leukocytes | 1 | 2005 | 295 | 0.050 |
Why?
| | Analgesia | 2 | 1994 | 105 | 0.050 |
Why?
| | Nucleus Accumbens | 2 | 2016 | 132 | 0.050 |
Why?
| | Biology | 1 | 2024 | 91 | 0.050 |
Why?
| | Cholesterol, LDL | 1 | 2005 | 353 | 0.050 |
Why?
| | Colony-Forming Units Assay | 1 | 2002 | 95 | 0.050 |
Why?
| | Dermatitis | 1 | 2002 | 18 | 0.050 |
Why?
| | Biomarkers | 3 | 2015 | 4254 | 0.050 |
Why?
| | Triglycerides | 1 | 2005 | 512 | 0.050 |
Why?
| | Forecasting | 1 | 2004 | 388 | 0.050 |
Why?
| | Hemoglobins | 1 | 2005 | 383 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 1992 | 1318 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2003 | 327 | 0.050 |
Why?
| | Hot Temperature | 2 | 2021 | 405 | 0.050 |
Why?
| | Cell Membrane | 1 | 2005 | 706 | 0.050 |
Why?
| | Naloxone | 3 | 2012 | 132 | 0.050 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 7 | 0.040 |
Why?
| | Molecular Chaperones | 1 | 2024 | 199 | 0.040 |
Why?
| | Cell Division | 1 | 2003 | 766 | 0.040 |
Why?
| | Acute Disease | 2 | 2002 | 1028 | 0.040 |
Why?
| | Immunologic Memory | 1 | 2004 | 366 | 0.040 |
Why?
| | Risk Factors | 1 | 2016 | 10699 | 0.040 |
Why?
| | Reflex, Startle | 2 | 2015 | 76 | 0.040 |
Why?
| | Universities | 1 | 2024 | 451 | 0.040 |
Why?
| | Epitopes | 1 | 2003 | 485 | 0.040 |
Why?
| | Injections, Intravenous | 2 | 1998 | 200 | 0.040 |
Why?
| | Immunoglobulin Isotypes | 1 | 2001 | 35 | 0.040 |
Why?
| | Middle Aged | 4 | 2024 | 35762 | 0.040 |
Why?
| | Hormone Antagonists | 1 | 2001 | 34 | 0.040 |
Why?
| | Mycobacteriaceae | 1 | 2021 | 35 | 0.040 |
Why?
| | Macrophage-1 Antigen | 1 | 2000 | 26 | 0.040 |
Why?
| | Learning | 3 | 2008 | 449 | 0.040 |
Why?
| | Neurons, Afferent | 2 | 1998 | 102 | 0.040 |
Why?
| | Spironolactone | 1 | 2001 | 39 | 0.040 |
Why?
| | Health Status | 1 | 2006 | 833 | 0.040 |
Why?
| | Skin | 2 | 2002 | 754 | 0.040 |
Why?
| | Complement Activation | 1 | 2003 | 411 | 0.040 |
Why?
| | Hypogravity | 1 | 1999 | 5 | 0.040 |
Why?
| | Receptors, Mineralocorticoid | 1 | 1999 | 11 | 0.040 |
Why?
| | Radiation Injuries, Experimental | 1 | 1999 | 20 | 0.040 |
Why?
| | Phenotype | 2 | 2021 | 3157 | 0.040 |
Why?
| | Cells | 1 | 1999 | 25 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 1999 | 140 | 0.040 |
Why?
| | Radiometry | 1 | 1999 | 56 | 0.040 |
Why?
| | Drug Combinations | 1 | 2001 | 390 | 0.040 |
Why?
| | Electrophysiology | 2 | 1999 | 218 | 0.040 |
Why?
| | Chronic Disease | 1 | 2006 | 1812 | 0.040 |
Why?
| | Obesity | 1 | 1993 | 3057 | 0.040 |
Why?
| | Restraint, Physical | 3 | 2010 | 75 | 0.040 |
Why?
| | Social Isolation | 1 | 1999 | 72 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 744 | 0.040 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 1999 | 99 | 0.040 |
Why?
| | alpha-MSH | 1 | 1998 | 6 | 0.040 |
Why?
| | Endotoxins | 1 | 2000 | 220 | 0.040 |
Why?
| | Eating | 3 | 2000 | 389 | 0.040 |
Why?
| | Erythrocytes | 1 | 2005 | 757 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 330 | 0.040 |
Why?
| | Peritoneal Cavity | 1 | 1998 | 30 | 0.040 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 3 | 2007 | 253 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 1999 | 102 | 0.040 |
Why?
| | Staphylococcal Infections | 2 | 2000 | 388 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 2154 | 0.030 |
Why?
| | Administration, Oral | 1 | 2001 | 847 | 0.030 |
Why?
| | United States | 1 | 2016 | 15876 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 198 | 0.030 |
Why?
| | Polysomnography | 1 | 2019 | 234 | 0.030 |
Why?
| | Electroencephalography | 1 | 2021 | 532 | 0.030 |
Why?
| | Individuality | 1 | 2019 | 152 | 0.030 |
Why?
| | CD4 Lymphocyte Count | 1 | 1998 | 274 | 0.030 |
Why?
| | Bacteriophages | 1 | 1999 | 111 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2929 | 0.030 |
Why?
| | Wakefulness | 1 | 2019 | 169 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2016 | 17009 | 0.030 |
Why?
| | Models, Biological | 1 | 2005 | 1820 | 0.030 |
Why?
| | Oxytocics | 1 | 1997 | 15 | 0.030 |
Why?
| | Models, Molecular | 2 | 2013 | 1618 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 1999 | 339 | 0.030 |
Why?
| | Antigens, CD | 1 | 2000 | 555 | 0.030 |
Why?
| | Monitoring, Physiologic | 2 | 2008 | 289 | 0.030 |
Why?
| | Altitude | 1 | 2001 | 473 | 0.030 |
Why?
| | Dinoprostone | 1 | 1997 | 178 | 0.030 |
Why?
| | Receptors, Purinergic P2X5 | 1 | 2016 | 4 | 0.030 |
Why?
| | Activating Transcription Factor 3 | 1 | 2016 | 5 | 0.030 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2016 | 15 | 0.030 |
Why?
| | p21-Activated Kinases | 1 | 2016 | 14 | 0.030 |
Why?
| | Weight Gain | 1 | 2000 | 556 | 0.030 |
Why?
| | Blotting, Western | 1 | 1999 | 1187 | 0.030 |
Why?
| | Sciatic Neuropathy | 1 | 2016 | 32 | 0.030 |
Why?
| | Orientation | 1 | 1996 | 50 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 2016 | 88 | 0.030 |
Why?
| | Anesthesia | 2 | 1990 | 257 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1993 | 3842 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 1997 | 213 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 1996 | 62 | 0.030 |
Why?
| | Synaptic Transmission | 1 | 1998 | 290 | 0.030 |
Why?
| | Azides | 1 | 1996 | 47 | 0.030 |
Why?
| | Occupational Exposure | 1 | 1999 | 354 | 0.030 |
Why?
| | Attention | 1 | 2019 | 455 | 0.030 |
Why?
| | Neuroglia | 1 | 2017 | 172 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2016 | 135 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2016 | 248 | 0.030 |
Why?
| | Functional Laterality | 1 | 2016 | 241 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 266 | 0.030 |
Why?
| | Dopaminergic Neurons | 1 | 2016 | 67 | 0.030 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 145 | 0.030 |
Why?
| | Stem Cells | 1 | 1999 | 625 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 219 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 169 | 0.030 |
Why?
| | Immobilization | 1 | 2015 | 53 | 0.030 |
Why?
| | Spinal Cord | 2 | 2004 | 380 | 0.030 |
Why?
| | Cytological Techniques | 1 | 1995 | 28 | 0.030 |
Why?
| | Drug Synergism | 2 | 2011 | 357 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2012 | 1253 | 0.030 |
Why?
| | Nylons | 1 | 1995 | 23 | 0.030 |
Why?
| | Neck | 1 | 1995 | 108 | 0.030 |
Why?
| | Macrophage Activation | 1 | 1996 | 193 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 457 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4562 | 0.030 |
Why?
| | Cholesterol | 1 | 1996 | 399 | 0.030 |
Why?
| | Melatonin | 1 | 2015 | 163 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 573 | 0.030 |
Why?
| | Memory, Short-Term | 2 | 2008 | 270 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 388 | 0.020 |
Why?
| | Phosphatidylserines | 1 | 2013 | 60 | 0.020 |
Why?
| | Static Electricity | 1 | 2013 | 113 | 0.020 |
Why?
| | Clonidine | 1 | 2013 | 33 | 0.020 |
Why?
| | CD4-CD8 Ratio | 1 | 1992 | 23 | 0.020 |
Why?
| | Amitriptyline | 1 | 2013 | 24 | 0.020 |
Why?
| | Myristoylated Alanine-Rich C Kinase Substrate | 1 | 2012 | 6 | 0.020 |
Why?
| | Neural Inhibition | 1 | 1994 | 178 | 0.020 |
Why?
| | Fasting | 1 | 2014 | 276 | 0.020 |
Why?
| | Neurogenesis | 1 | 2014 | 156 | 0.020 |
Why?
| | Unilamellar Liposomes | 1 | 2012 | 8 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2006 | 6021 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 168 | 0.020 |
Why?
| | Drug Administration Routes | 1 | 2012 | 42 | 0.020 |
Why?
| | Anthropometry | 1 | 1993 | 199 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2012 | 149 | 0.020 |
Why?
| | Pituitary-Adrenal Function Tests | 1 | 2012 | 3 | 0.020 |
Why?
| | Pain Threshold | 1 | 2012 | 73 | 0.020 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 88 | 0.020 |
Why?
| | Adolescent Health Services | 1 | 1993 | 75 | 0.020 |
Why?
| | Self Administration | 1 | 2012 | 124 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2012 | 75 | 0.020 |
Why?
| | Hand Strength | 2 | 2004 | 143 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2013 | 213 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 175 | 0.020 |
Why?
| | Sex Factors | 2 | 2008 | 2096 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 114 | 0.020 |
Why?
| | Sialoglycoproteins | 2 | 2004 | 158 | 0.020 |
Why?
| | Linear Models | 2 | 2004 | 850 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 1992 | 251 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1992 | 177 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 329 | 0.020 |
Why?
| | Arginine Vasopressin | 1 | 1990 | 44 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2006 | 11643 | 0.020 |
Why?
| | Pentobarbital | 1 | 1990 | 17 | 0.020 |
Why?
| | Urethane | 1 | 1990 | 43 | 0.020 |
Why?
| | Liposomes | 1 | 2012 | 249 | 0.020 |
Why?
| | Vasopressins | 1 | 1990 | 60 | 0.020 |
Why?
| | Behavior Therapy | 1 | 1993 | 281 | 0.020 |
Why?
| | Adolescent | 3 | 2004 | 22281 | 0.020 |
Why?
| | Narcotic Antagonists | 1 | 2012 | 204 | 0.020 |
Why?
| | Risk Assessment | 1 | 1999 | 3637 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1992 | 919 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 2010 | 165 | 0.020 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2009 | 9 | 0.020 |
Why?
| | Immunity, Mucosal | 1 | 2011 | 98 | 0.020 |
Why?
| | Serotonin Receptor Agonists | 1 | 2009 | 27 | 0.020 |
Why?
| | Serotonin Antagonists | 1 | 2009 | 30 | 0.020 |
Why?
| | Aged, 80 and over | 3 | 2008 | 8243 | 0.020 |
Why?
| | Noise | 1 | 2010 | 71 | 0.020 |
Why?
| | Drinking | 2 | 1999 | 42 | 0.020 |
Why?
| | Bites and Stings | 1 | 1989 | 29 | 0.020 |
Why?
| | Program Evaluation | 1 | 1993 | 946 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2011 | 195 | 0.020 |
Why?
| | Posture | 1 | 1989 | 196 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 462 | 0.020 |
Why?
| | Injections, Intramuscular | 1 | 2008 | 141 | 0.020 |
Why?
| | Amine Oxidase (Copper-Containing) | 1 | 2007 | 5 | 0.020 |
Why?
| | E-Selectin | 1 | 2007 | 61 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2182 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 200 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 901 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2007 | 138 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2006 | 69 | 0.020 |
Why?
| | Epithelial Sodium Channels | 1 | 2006 | 21 | 0.020 |
Why?
| | Action Potentials | 3 | 1999 | 506 | 0.010 |
Why?
| | Cell Line | 1 | 1992 | 2879 | 0.010 |
Why?
| | Sodium Channels | 1 | 2006 | 63 | 0.010 |
Why?
| | Protein Binding | 1 | 2012 | 2270 | 0.010 |
Why?
| | Nanoparticles | 1 | 2012 | 519 | 0.010 |
Why?
| | Models, Animal | 1 | 2007 | 392 | 0.010 |
Why?
| | Epithelium | 1 | 2006 | 314 | 0.010 |
Why?
| | Receptors, HIV | 1 | 2004 | 23 | 0.010 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2004 | 19 | 0.010 |
Why?
| | Autoimmunity | 1 | 1991 | 924 | 0.010 |
Why?
| | Chemokine CX3CL1 | 1 | 2004 | 25 | 0.010 |
Why?
| | Receptors, Cytokine | 1 | 2004 | 36 | 0.010 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2004 | 30 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1047 | 0.010 |
Why?
| | Bronchi | 1 | 2006 | 267 | 0.010 |
Why?
| | Injections, Spinal | 1 | 2004 | 120 | 0.010 |
Why?
| | Drug Tolerance | 1 | 2004 | 100 | 0.010 |
Why?
| | Drug Implants | 2 | 1996 | 83 | 0.010 |
Why?
| | Complement C4a | 1 | 2003 | 9 | 0.010 |
Why?
| | Hormones | 1 | 2004 | 134 | 0.010 |
Why?
| | Social Environment | 2 | 1996 | 254 | 0.010 |
Why?
| | Catheterization | 1 | 2004 | 183 | 0.010 |
Why?
| | Histamine | 1 | 2003 | 53 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 2003 | 167 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2004 | 765 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2004 | 192 | 0.010 |
Why?
| | Isometric Contraction | 1 | 2004 | 188 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2004 | 313 | 0.010 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2001 | 27 | 0.010 |
Why?
| | Electromyography | 1 | 2004 | 415 | 0.010 |
Why?
| | Anaerobic Threshold | 1 | 2001 | 28 | 0.010 |
Why?
| | Mental Status Schedule | 1 | 2001 | 35 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2004 | 428 | 0.010 |
Why?
| | Cholecystokinin | 1 | 2000 | 15 | 0.010 |
Why?
| | Mathematics | 1 | 2001 | 100 | 0.010 |
Why?
| | Menstrual Cycle | 1 | 2001 | 140 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2000 | 81 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 2000 | 187 | 0.010 |
Why?
| | Pain Management | 1 | 2004 | 405 | 0.010 |
Why?
| | Dimerization | 1 | 2000 | 193 | 0.010 |
Why?
| | Allergens | 1 | 2003 | 384 | 0.010 |
Why?
| | Listeriosis | 1 | 2000 | 65 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 163 | 0.010 |
Why?
| | Ovary | 1 | 2001 | 228 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2006 | 935 | 0.010 |
Why?
| | Therapeutic Irrigation | 1 | 2000 | 69 | 0.010 |
Why?
| | Cerebellum | 1 | 2000 | 223 | 0.010 |
Why?
| | Glossopharyngeal Nerve | 1 | 1998 | 11 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2001 | 724 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5389 | 0.010 |
Why?
| | Afferent Pathways | 1 | 1998 | 46 | 0.010 |
Why?
| | Rats, Long-Evans | 1 | 1998 | 125 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 13990 | 0.010 |
Why?
| | Nodose Ganglion | 1 | 1997 | 5 | 0.010 |
Why?
| | Cerebral Cortex | 1 | 2000 | 464 | 0.010 |
Why?
| | Amnesia, Retrograde | 1 | 1996 | 6 | 0.010 |
Why?
| | Appetitive Behavior | 1 | 1996 | 7 | 0.010 |
Why?
| | Sodium Azide | 1 | 1996 | 6 | 0.010 |
Why?
| | Synaptic Membranes | 1 | 1996 | 16 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1996 | 41 | 0.010 |
Why?
| | Zymosan | 1 | 1996 | 39 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3592 | 0.010 |
Why?
| | Space Perception | 1 | 1996 | 83 | 0.010 |
Why?
| | Neoplasms | 1 | 2011 | 2870 | 0.010 |
Why?
| | Chlorisondamine | 1 | 1994 | 3 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 9 | 0.010 |
Why?
| | Skin Temperature | 1 | 1993 | 35 | 0.010 |
Why?
| | Binding Sites | 1 | 1996 | 1327 | 0.010 |
Why?
| | Child | 1 | 1993 | 22537 | 0.010 |
Why?
| | Pyramidal Tracts | 1 | 1992 | 30 | 0.010 |
Why?
| | Cold Temperature | 1 | 1993 | 207 | 0.010 |
Why?
| | Regression Analysis | 1 | 1992 | 998 | 0.000 |
Why?
| | Mitochondria | 1 | 1996 | 983 | 0.000 |
Why?
| | Immunoglobulin gamma-Chains | 1 | 1988 | 2 | 0.000 |
Why?
|
|
Fleshner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|